A CROSS SECTIONAL ONLINE SURVEY ON SYMPTOMS FOLLOWING COVID-19 VACCINATION

ELAKKIYA, P. and KURUSHEV, JAYESTRI (2022) A CROSS SECTIONAL ONLINE SURVEY ON SYMPTOMS FOLLOWING COVID-19 VACCINATION. Journal of Medicine and Health Research, 7 (1). pp. 28-35. ISSN 2456-9178

Full text not available from this repository.

Abstract

Background: COVID-19 vaccination is the administration of a vaccine to help the individuals to protect from COVID-19. COVID-19 vaccines have been unfurled in several parts of the world. Although the protective efficacy was frequently discussed and analysed, little is known about post-vaccination experience outside of clinical trial conditions. The aim of the study was symptoms following COVID-19 vaccination in selected area, Puducherry, with the objectives of to assess the immediate response to the first dose of COVID-19 vaccine and to study the spectrum of post-vaccination symptom profile for individual vaccines.

Methodology: Quantitative approach and non-experimental cross-sectional design was used. The study was conducted in selected areas in Puducherry. 30 subjects were recruited by using convenience sampling technique. Demographic variable questionnaire and self-developed binary tools was used.

Results: The study results revealed that the Overall, all 30(100%) of respondents reported at least one post-vaccination symptom. 9(30%) had the symptoms of body ache, 7(23.3%) had fever, 6(20%) had local pain at injection site, 5(16.7%) had tiredness and 3(10%). Among male 10(33.3%) had paracetamol intake, 3(10%) had symptoms following vaccine, 4(13.3%) had symptoms within duration of hours and only 1(3.3%) had symptoms after onset in hours. Among female 10(33.3%) had taken paracetamol, 9(30%) had symptoms following vaccine, 7(23.4%) had symptoms within duration of hours and only 4(13.4%) had symptoms after onset in hours.

Conclusion: Body ache and fever was most commonly reported. These symptoms were consistent with an immune response commonly associated with vaccines. In 90% cases, the symptoms were either milder than expected or meeting the expectation of the vaccine recipient. No serious events were reported. Symptoms were more common among younger individuals.

Item Type: Article
Subjects: Opene Prints > Medical Science
Depositing User: Managing Editor
Date Deposited: 07 Dec 2023 03:51
Last Modified: 07 Dec 2023 03:51
URI: http://geographical.go2journals.com/id/eprint/3245

Actions (login required)

View Item
View Item